UpdatedS2K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)

医学 性病学 皮肤病科 硫唑嘌呤 大疱性类天疱疮 氨苯砜 强的松 指南 类天疱疮 甲氨蝶呤 疾病 外科 内科学 免疫学 病理 抗体
作者
Luca Borradori,Nina van Beek,Claudio Feliciani,Billal Tedbirt,Emiliano Antiga,Richard N. Bergman,Barbara C. Böckle,Marzia Caproni,F. Caux,Nisha Suyien Chandran,Giuseppe Cianchini,Maryam Daneshpazhooh,Dipankar De,Dario Didona,Giovanni Di Zenzo,Marian Dmochowski,Kossara Drenovska,Jan Ehrchen,Matthias Goebeler,Richard Groves
出处
期刊:Journal of The European Academy of Dermatology and Venereology [Wiley]
卷期号:36 (10): 1689-1704 被引量:140
标识
DOI:10.1111/jdv.18220
摘要

Abstract Background Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disease of the skin and mucous membranes. This disease typically affects the elderly and presents with itch and localized or, most frequently, generalized bullous lesions. A subset of patients only develops excoriations, prurigo‐like lesions, and eczematous and/or urticarial erythematous lesions. The disease, which is significantly associated with neurological disorders, has high morbidity and severely impacts the quality of life. Objectives and methodology The Autoimmune blistering diseases Task Force of the European Academy of Dermatology and Venereology sought to update the guidelines for the management of BP based on new clinical information, and new evidence on diagnostic tools and interventions. The recommendations are either evidence‐based or rely on expert opinion. The degree of consent among all task force members was included. Results Treatment depends on the severity of BP and patients' comorbidities. High‐potency topical corticosteroids are recommended as the mainstay of treatment whenever possible. Oral prednisone at a dose of 0.5 mg/kg/day is a recommended alternative. In case of contraindications or resistance to corticosteroids, immunosuppressive therapies, such as methotrexate, azathioprine, mycophenolate mofetil or mycophenolate acid, may be recommended. The use of doxycycline and dapsone is controversial. They may be recommended, in particular, in patients with contraindications to oral corticosteroids. B‐cell‐depleting therapy and intravenous immunoglobulins may be considered in treatment‐resistant cases. Omalizumab and dupilumab have recently shown promising results. The final version of the guideline was consented to by several patient organizations. Conclusions The guidelines for the management of BP were updated. They summarize evidence‐ and expert‐based recommendations useful in clinical practice.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
万能图书馆应助JoanJin采纳,获得10
1秒前
li发布了新的文献求助10
1秒前
1秒前
1秒前
1秒前
杨柳飞洋完成签到,获得积分10
1秒前
2秒前
llee2005完成签到,获得积分10
2秒前
廉泽完成签到,获得积分10
2秒前
2秒前
啦啦啦4396完成签到,获得积分20
3秒前
欣观发布了新的文献求助10
3秒前
飞龙在天发布了新的文献求助10
3秒前
3秒前
3秒前
4秒前
4秒前
自信之卉完成签到,获得积分10
4秒前
Dryad完成签到,获得积分10
4秒前
huahua发布了新的文献求助10
4秒前
4秒前
星星又累完成签到,获得积分10
5秒前
5秒前
5秒前
psydaodao发布了新的文献求助10
6秒前
6秒前
fairyinn发布了新的文献求助10
6秒前
LamChem完成签到,获得积分20
6秒前
wiedii完成签到,获得积分10
6秒前
huifang发布了新的文献求助10
7秒前
凸凸完成签到,获得积分10
7秒前
7秒前
7秒前
缓慢珠发布了新的文献求助10
8秒前
~桃完成签到,获得积分10
8秒前
古城小街发布了新的文献求助10
8秒前
向会妍完成签到,获得积分10
8秒前
乐观的雨发布了新的文献求助20
8秒前
想发JACS的永康完成签到,获得积分10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
晶种分解过程与铝酸钠溶液混合强度关系的探讨 8888
Les Mantodea de Guyane Insecta, Polyneoptera 2000
The Organometallic Chemistry of the Transition Metals 800
Leading Academic-Practice Partnerships in Nursing and Healthcare: A Paradigm for Change 800
Signals, Systems, and Signal Processing 610
The formation of Australian attitudes towards China, 1918-1941 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6419992
求助须知:如何正确求助?哪些是违规求助? 8239187
关于积分的说明 17507143
捐赠科研通 5473114
什么是DOI,文献DOI怎么找? 2891451
邀请新用户注册赠送积分活动 1868234
关于科研通互助平台的介绍 1705406